Stroke is the leading cause of disability in the US, and, apart from physical therapy, therapeutic options to reduce this burden are non-existent. Following a stroke, cell death and glial scarring leads to the formation of a non- regenerative stroke cavity surrounded by the regenerative peri-infarct region. We are interested in understanding how bioengineered therapeutics can synergize with pro-repair programs active in the peri-infarct region to promote tissue regeneration in the stroke cavity and thereby improve neurological recovery. We have previously engineered a dual-acting angiogenic hydrogel that, when injected into the stroke cavity, can reduce glial scarring and promote vascularization to allow axonal infiltration. Although achieving brain repair in the stroke cavity is remarkable, these results were achieved in young mice with un-impaired neuroplasticity. We believe that to bring this technology closer to clinical translation, we must be able to show similar brain repair and behavioral improvement in more clinically relevant animal models, like aged mice with decreased neuroplasticity. In this application, we aim to identify our angiogenic hydrogel?s mechanism of action and optimize its formulation and to utilize this new formulation in a stroke models with decreased neuroplasticity. The hydrogel is composed of hyaluronic acid functionalized with cell-binding integrins and loaded with clustered vascular endothelial growth factor (VEGF) and heparin nanoparticles. Heparin is a known anti-inflammatory agent that potentially acts by breaking the inflammatory cycle between macrophages and astrocytes following stroke. We will use design of experiment methodology to determine the composition of these three factors (integrins, clustered VEGF, and heparin nanoparticles) that leads to substantial brain repair (Aim 1) and assess how the hydrogel components modulate the pro-repair environment by analyzing temporal changes in proteins, mRNA, and immune cell populations following stroke (Aim 2). Using the improved formulation, we will also evaluate the angiogenic hydrogel?s ability to promote neurological regeneration and functional recovery in more rigorous animal models, specifically aged mice treated immediately following cerebral ischemia and young mice with cerebral ischemia treated as the plasticity window is closing (Aim 3). Overall, we aim to deepen our understanding of how bioengineered therapeutics synergize with endogenous pro-regenerative programs and thereby improve behavioral outcomes following stoke in more difficult-to-treat cases.

Public Health Relevance

Stroke is the leading cause of adult disability and no current treatments exist beyond physical therapy. This proposal explores the mechanism of action of a biomaterial based therapy to promote recovery after stroke aiming to reduce stroke induced disability. Understanding the mechanism of action will provide new therapeutic targets to further improve recovery and reduce disability after stroke.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS079691-07
Application #
10091531
Study Section
Biomaterials and Biointerfaces Study Section (BMBI)
Program Officer
Koenig, James I
Project Start
2012-05-01
Project End
2024-11-30
Budget Start
2020-12-01
Budget End
2021-11-30
Support Year
7
Fiscal Year
2021
Total Cost
Indirect Cost
Name
Duke University
Department
Biomedical Engineering
Type
Biomed Engr/Col Engr/Engr Sta
DUNS #
044387793
City
Durham
State
NC
Country
United States
Zip Code
27705
Dimatteo, Robert; Darling, Nicole J; Segura, Tatiana (2018) In situ forming injectable hydrogels for drug delivery and wound repair. Adv Drug Deliv Rev 127:167-184
Nih, Lina R; Gojgini, Shiva; Carmichael, S Thomas et al. (2018) Dual-function injectable angiogenic biomaterial for the repair of brain tissue following stroke. Nat Mater 17:642-651
Zhu, Suwei; Li, Shuoran; Escuin-Ordinas, Helena et al. (2018) Accelerated wound healing by injectable star poly(ethylene glycol)-b-poly(propylene sulfide) scaffolds loaded with poorly water-soluble drugs. J Control Release 282:156-165
Li, Shuoran; Nih, Lina R; Bachman, Haylee et al. (2017) Hydrogels with precisely controlled integrin activation dictate vascular patterning and permeability. Nat Mater 16:953-961
Nih, Lina R; Moshayedi, Pouria; Llorente, Irene L et al. (2017) Engineered HA hydrogel for stem cell transplantation in the brain: Biocompatibility data using a design of experiment approach. Data Brief 10:202-209
Zhu, Suwei; Segura, Tatiana (2016) Cell-Demanded VEGF Release via Nanocapsules Elicits Different Receptor Activation Dynamics and Enhanced Angiogenesis. Ann Biomed Eng 44:1983-92
Nih, Lina Ratiba; Carmichael, Stanley Thomas; Segura, Tatiana (2016) Hydrogels for brain repair after stroke: an emerging treatment option. Curr Opin Biotechnol 40:155-163
Moshayedi, Pouria; Nih, Lina R; Llorente, Irene L et al. (2016) Systematic optimization of an engineered hydrogel allows for selective control of human neural stem cell survival and differentiation after transplantation in the stroke brain. Biomaterials 105:145-155
Griffin, Donald R; Weaver, Westbrook M; Scumpia, Philip O et al. (2015) Accelerated wound healing by injectable microporous gel scaffolds assembled from annealed building blocks. Nat Mater 14:737-44
Lam, Jonathan; Carmichael, S Thomas; Lowry, William E et al. (2015) Hydrogel design of experiments methodology to optimize hydrogel for iPSC-NPC culture. Adv Healthc Mater 4:534-9

Showing the most recent 10 out of 17 publications